Two distinct DNA binding modes guide dual roles of a CRISPR-cas protein complex

Journal Article (2015)
Author(s)

Timothy R. Blosser (TU Delft - BN/Cees Dekker Lab, Kavli institute of nanoscience Delft, Broad Institute of MIT and Harvard)

Luuk Loeff (Kavli institute of nanoscience Delft, TU Delft - BN/Chirlmin Joo Lab)

Edze R. Westra (Wageningen University & Research, University of Exeter)

Marnix Vlot (Wageningen University & Research)

Tim Künne (Wageningen University & Research)

Małgorzata Sobota (Wageningen University & Research)

Cees Dekker (TU Delft - BN/Cees Dekker Lab, Kavli institute of nanoscience Delft)

Stan J J Brouns (Wageningen University & Research, TU Delft - BN/Stan Brouns Lab)

Chirlmin Joo (Kavli institute of nanoscience Delft, TU Delft - BN/Chirlmin Joo Lab)

DOI related publication
https://doi.org/10.1016/j.molcel.2015.01.028 Final published version
More Info
expand_more
Publication Year
2015
Language
English
Issue number
1
Volume number
58
Pages (from-to)
60-70
Downloads counter
216

Abstract

Small RNA-guided protein complexes play an essential role in CRISPR-mediated immunity in prokaryotes. While these complexes initiate interference byflagging cognate invader DNA for destruction, recent evidence has implicated their involvement innew CRISPR memory formation, called priming, against mutated invader sequences. The mechanism by which the target recognition complex mediates these disparate responses-interference and priming-remains poorly understood. Using single-molecule FRET, we visualize how bona fide and mutated targets are differentially probed by E.coli Cascade. We observe that the recognition of bona fide targets is an ordered process that is tightly controlled forhigh fidelity. Mutated targets are recognized with low fidelity, which is featured by short-lived and PAM- and seed-independent binding by any segment of the crRNA. These dual roles of Cascade in immunity with distinct fidelities underpin CRISPR-Cas robustness, allowing for efficient degradation ofbona fide targets and priming of mutated DNA targets.